These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24314937)

  • 1. Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels.
    Uyar ME; Tutal E; Bal Z; Sezer S
    Transplant Proc; 2013; 45(10):3481-4. PubMed ID: 24314937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition analysis of patients on waiting list for cadaveric renal transplantation: a comparison of hemodialysis and peritoneal dialysis patients.
    Bal Z; Uyar ME; Tutal E; Guliyev O; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3489-93. PubMed ID: 24314939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
    Abe M; Okada K; Soma M; Matsumoto K
    Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance index to epoetin alpha and to darbepoetin-alpha in chronic hemodialysis patients: a cohort study].
    Pérez-García R; Rodríguez Benítez P; Jofre R; López-Gómez JM; Villaverde MT; Blanco A; Blanco S; Sánchez M
    Nefrologia; 2007; 27(3):340-9. PubMed ID: 17725454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.
    Hasegawa T; Bragg-Gresham JL; Pisoni RL; Robinson BM; Fukuhara S; Akiba T; Saito A; Kurokawa K; Akizawa T
    Kidney Int; 2011 Feb; 79(3):340-6. PubMed ID: 20962740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.
    Gaweda AE; Goldsmith LJ; Brier ME; Aronoff GR
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):576-81. PubMed ID: 20110344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intravenous epoetin-alpha / darbepoetin-alpha ratio in iron-replete hemodialysis patients.
    Icardi A; Sacco P; Salvatore F; Romano U
    J Nephrol; 2007; 20(1):73-9. PubMed ID: 17347977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
    Foley RN; Curtis BM; Parfrey PS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It's time to compare anemia management strategies in hemodialysis.
    Coyne DW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trial.
    Brimble KS; Rabbat CG; McKenna P; Lambert K; Carlisle EJ
    J Am Soc Nephrol; 2003 Oct; 14(10):2654-61. PubMed ID: 14514745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of hemodialysis patients - a comparison with Mini Nutritional Assessment.
    Erdoğan E; Tutal E; Uyar ME; Bal Z; Demirci BG; Sayın B; Sezer S
    Transplant Proc; 2013; 45(10):3485-8. PubMed ID: 24314938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin maintenance and dosing strategies using intravenous continuous erythropoietin receptor activator in Japanese hemodialysis patients.
    Hirai T; Nishizawa Y; Nakazono H; Asai M; Yamashita H; Sasaki A; Yamashita T; Yamashita K; Shigemoto K; Harada S; Mizuiri S
    Ther Apher Dial; 2013 Oct; 17(5):498-503. PubMed ID: 24107278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
    Fishbane S; Berns JS
    Kidney Int; 2005 Sep; 68(3):1337-43. PubMed ID: 16105069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.
    Levin A; Djurdjev O; Thompson C; Barrett B; Ethier J; Carlisle E; Barre P; Magner P; Muirhead N; Tobe S; Tam P; Wadgymar JA; Kappel J; Holland D; Pichette V; Shoker A; Soltys G; Verrelli M; Singer J
    Am J Kidney Dis; 2005 Nov; 46(5):799-811. PubMed ID: 16253719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Lacson E; Ofsthun N; Lazarus JM
    Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa.
    Chazot C; Terrat JC; Dumoulin A; Ang KS; Gassia JP; Chedid K; Maurice F; Canaud B;
    Ann Pharmacother; 2009 Feb; 43(2):228-34. PubMed ID: 19407262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible influence of vitamin D receptor gene polymorphisms on recombinant human erythropoietin requirements in dialysis patients.
    Sezer S; Tutal E; Bilgic A; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):40-4. PubMed ID: 17275471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.